Save Time and Money by Increasing Trial Access

Reduce trial costs and enrollment timelines by expanding your trial’s access to every body, everywhere. Provide your patients with a simple and engaging way to see if they’re eligible for your next trial.

  • 3,000+ patients screened per month, globally
  • $20M in customer cost savings for one trial
  • 50% reduction In customer enrollment timelines for one trial
  • 75% reduction In customer clinical trial sites for one trial

Maximize your trials' efficiencies by expanding research to everybody

Our trial solutions help create efficiency in clinical development, expanding research to everyone, and bringing more treatments to market faster. It’s because of this that we’ve been able to:

Release the industry’s first ever quantitative data showcasing the benefit of DCTs, authored by Tufts CSDD.
Be named the number one provider of DCT, by Everest
The most experience in decentralized trials with 150+ DCTs.

Complete the form below to get started on accelerating your trials enrollment.

Entrust the Decentralized Clinical Trial platform with the most global experience.

1m

Patients helped

60+

Languages

150+

Studies completed

60+

Countries

In partnering with Medable, we look to combine Accenture’s extensive industry and professional services expertise with Medable’s proven and cutting-edge platform to deliver winning outcomes at the forefront of the digital age. Together, we will be able to help our life sciences partners accelerate clinical trials and improve the patient experience by scaling decentralized clinical trials across their enterprise.

Nicole Paraggio
Strategy Managing Director, Accenture

Our collaboration with Medable will identify opportunities to capture data – real time – to better deliver customized, decentralized solutions. When combined with our Illingworth Research Group mobile research nursing capabilities, we believe we’ll be able to engage more diverse populations and increase access for patients who previously couldn’t participate in clinical trials.

Maria Fotiu
Executive Vice President for Decentralized Solutions, Syneos Health

We share Medable’s vision for patient-centric research and clinical improvement, and we’re excited to expand the expert services available for Medable’s industry-leading platform. Working together, we can collaborate with pharma sponsors to transform their clinical research to start up quicker, reduce patient burden, and ultimately bring therapies to market faster.

Avi Kulkarni
Senior Vice President for Life Sciences R&D, Cognizant

This dynamic collaboration with Medable will help us intensify our efforts to drive meaningful awareness and access to a broader population, in particular those with mounting chronic illness and the vulnerable populations who today are underrepresented in clinical research. Those populations often have limited access to health care, and therefore a greater chance of poor health and lower life expectancy. Over 40% of the vulnerable population in the U.S. lives within five miles of a CVS Pharmacy location, so we have a chance to engage them.

Tony Clapsis
General Manager and Senior Vice President, CVS Health Clinical Trial Services

Accelerating the pace of clinical development will help patients get access to life-saving therapies more quickly. We're excited to help power Medable's work in accelerating clinical trials by making it easier to connect to the ecosystem of real-world data.

Travis May
CEO, Datavant

Our partnership between Medable and Oracle ClinicalOne, based on our proven interoperable technology, is streamlining decentralized trials - truly putting the patients at the center of the trials while providing robust data analysis for sites that can unlock better insights and ultimately outcomes for sponsors.

Henry McNamara
GM, HSGBU

---

---
PPD

Through our collaboration with Medable, PwC supports Sponsor adoption of decentralized clinical trials (DCT), positioning study teams for success on both a global and regional scale.  Our proven approach and digital tools help identify the right trials, optimize study design, and simplify study start-up through conduct, resulting in a truly patient-centric clinical trial.

Ian Shafer
Principal, PwC Pharma R&D

Our collaboration with Medable will identify opportunities to capture data – real time – to better deliver customized, decentralized solutions. When combined with our Illingworth Research Group mobile research nursing capabilities, we believe we’ll be able to engage more diverse populations and increase access for patients who previously couldn’t participate in clinical trials.

Maria Fotiu
Executive Vice President for Decentralized Solutions, Syneos Health

The services we offer around in-home care, patient-centric logistics, testing and diagnostics, and virtual site capabilities are an ideal complement to Medable’s patient-focused clinical trial platform. Together we can bridge the gap between clinical care and clinical research, paving the way for much simpler and faster decentralization in clinical trials.

Jason Feldman
CEO and co-founder, Vault Health

In partnering with Medable, we look to combine Accenture’s extensive industry and professional services expertise with Medable’s proven and cutting-edge platform to deliver winning outcomes at the forefront of the digital age. Together, we will be able to help our life sciences partners accelerate clinical trials and improve the patient experience by scaling decentralized clinical trials across their enterprise.

Nicole Paraggio
Strategy Managing Director, Accenture

We share Medable’s vision for patient-centric research and clinical improvement, and we’re excited to expand the expert services available for Medable’s industry-leading platform. Working together, we can collaborate with pharma sponsors to transform their clinical research to start up quicker, reduce patient burden, and ultimately bring therapies to market faster.

Avi Kulkarni
Senior Vice President for Life Sciences R&D, Cognizant

This dynamic collaboration with Medable will help us intensify our efforts to drive meaningful awareness and access to a broader population, in particular those with mounting chronic illness and the vulnerable populations who today are underrepresented in clinical research. Those populations often have limited access to health care, and therefore a greater chance of poor health and lower life expectancy. Over 40% of the vulnerable population in the U.S. lives within five miles of a CVS Pharmacy location, so we have a chance to engage them.

Tony Clapsis
General Manager and Senior Vice President, CVS Health Clinical Trial Services

Accelerating the pace of clinical development will help patients get access to life-saving therapies more quickly. We're excited to help power Medable's work in accelerating clinical trials by making it easier to connect to the ecosystem of real-world data.

Travis May
CEO, Datavant

Our partnership between Medable and Oracle ClinicalOne, based on our proven interoperable technology, is streamlining decentralized trials - truly putting the patients at the center of the trials while providing robust data analysis for sites that can unlock better insights and ultimately outcomes for sponsors.

Henry McNamara
GM, HSGBU

Through our collaboration with Medable, PwC supports Sponsor adoption of decentralized clinical trials (DCT), positioning study teams for success on both a global and regional scale.  Our proven approach and digital tools help identify the right trials, optimize study design, and simplify study start-up through conduct, resulting in a truly patient-centric clinical trial.

Ian Shafer
Principal, PwC Pharma R&D

Our collaboration with Medable will identify opportunities to capture data – real time – to better deliver customized, decentralized solutions. When combined with our Illingworth Research Group mobile research nursing capabilities, we believe we’ll be able to engage more diverse populations and increase access for patients who previously couldn’t participate in clinical trials.

Maria Fotiu
Executive Vice President for Decentralized Solutions, Syneos Health

The services we offer around in-home care, patient-centric logistics, testing and diagnostics, and virtual site capabilities are an ideal complement to Medable’s patient-focused clinical trial platform. Together we can bridge the gap between clinical care and clinical research, paving the way for much simpler and faster decentralization in clinical trials.

Jason Feldman
CEO and co-founder, Vault Health
Everest Matrix Report

Learn why Everest named Medable No.1 in DCT.

Grab your free copy of the Everest report to see how they ranked the top-15 DCT providers and why Medable is number one.

New research from Tufts CSDD and Medable shows how we can offer you:

New research from Tufts CSDD and Medable shows how we can offer you:

More on Medable and DCTs.

Research for Every Body, and Every Biology
Financial modeling from Tufts Center for the Study of Drug Development demonstrates substantial net benefits to sponsors who use decentralized clinical trials (DCTs) technology
Increasing Diversity in Clinical Trials

Why Medable Remote Screening?

Global Site Network Partnerships:
AES and Synexus
Patient Sourcing & Qualification:
Identify & screen 10,000+ patients per day from a pool of 100M+
Patient-Directed Scheduling:
Enable 30,000+ patients per month to select & schedule appointments
Patient Visits:
Provide in-person or remote visits to 180+ research sites in 17 countries
CROs
This is some text inside of a div block.
CROs
This is some text inside of a div block.
CROs
This is some text inside of a div block.

CROs
This is some text inside of a div block.
CROs
This is some text inside of a div block.
CROs
This is some text inside of a div block.
CROs
This is some text inside of a div block.